2012China Modern DoctorRequires access

Research progress of letrozole in inducing ovulation of women infertility

Qian Qiuran

Open publisher page 0 citations

Abstract

Letrozole is the third-generation aromatase inhibitor and it is mainly applied in the treatment for menopausal women with breast cancer.Recent studies showed that letrozole is an effective drug for clinical ovulation induction.Currently,letrozole is mainly applied in the following several aspects:first,applied in clinical ovulation induction for patients with CC-resistance in polycystic ovarian syndrome;secondly,applied in poor ovarian responders in IVF cycles to improve the pregnancy outcomes and reduce the gonadotropin dosages as well as treatment cost;thirdly,applied in ovulation induction for patients with cancer especially breast cancer without apparent teratogenic effects for fetus.This text elaborates the characteristic and mechanism of letrozole in clinical ovulation and its application in ovulation induction treatment.Letrozole may be a new first-line drug for ovulation induction.

About this research paper

What this paper is about

Letrozole is the third-generation aromatase inhibitor and it is mainly applied in the treatment for menopausal women with breast cancer.Recent studies showed that letrozole is an effective drug for clinical ovulation induction.Currently,letrozole is mainly applied in the following several aspects:first,applied in clinical ovulation induction for patients with CC-resistance in polycystic ovarian syndrome;secondly,applied in poor ovarian responders in IVF cycles to improve the pregnancy outcomes and reduce the gonadotropin dosages as well as treatment cost;thirdly,applied in ovulation induction for patients with cancer especially breast cancer without apparent teratogenic effects for fetus.This text elaborates the characteristic and mechanism of letrozole in clinical ovulation and its application in ovulation induction treatment.Letrozole may be a new first-line drug for ovulation induction.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Letrozole is the third-generation aromatase inhibitor and it is mainly applied in the treatment for menopausal women with breast cancer.Recent studies showed that letrozole is an effective drug for clinical ovulation induction.Currently,letrozole is mainly applied in the following several aspects:first,applied in clinical ovulation induction for patients with CC-resistance in polycystic ovarian syndrome;secondly,applied in poor ovarian responders in IVF cycles to improve the pregnancy outcomes and reduce the gonadotropin dosages as well as treatment cost;thirdly,applied in ovulation induction for patients with cancer especially breast cancer without apparent teratogenic effects for fetus.This text elaborates the characteristic and mechanism of letrozole in clinical ovulation and its application in ovulation induction treatment.Letrozole may be a new first-line drug for ovulation induction.

Key concepts: Letrozole, Medicine, Ovulation induction, Ovulation, Aromatase inhibitor, Infertility, Gynecology, Pregnancy

Related papers

Back to paper searchBrowse research topicsOriginal source
Research progress of letrozole in inducing ovulation of women infertility — Research Paper | ScholarLens